Device Cardiology/Vascular Diseases

Edora 8 Dr-T

Payments companies reported to CMS as associated with Edora 8 Dr-T. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$243Kassociated payments (2023-2025)
521clinicians with associated payments
1company reporting

By year

2023 $236K
2024 $6,094

Payments reported as associated with Edora 8 Dr-T, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $189K
Cardiovascular Disease $26K
Internal Medicine $7,155
Interventional Cardiology $3,321
Physician Assistant $1,554
Nurse Practitioner $1,258

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Edora 8 Dr-T

These are the largest totals companies reported as associated with Edora 8 Dr-T. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gaurav Upadhyay Chicago, IL Clinical Cardiac Electrophysiology $86,650.35
David Frazier Greenville, NC Clinical Cardiac Electrophysiology $8,147.10
Atul Prakash Clifton, NJ Clinical Cardiac Electrophysiology $4,000.00
Roderick Tung Chicago, IL Clinical Cardiac Electrophysiology $2,891.82
Antonio Moretta Sarasota, FL Clinical Cardiac Electrophysiology $2,277.27
Kalyanam Shivkumar Los Angeles, CA Cardiovascular Disease $1,909.72
Asad Mohammad New York, NY Clinical Cardiac Electrophysiology $1,866.36
Gregory Harris Greenville, NC Clinical Cardiac Electrophysiology $1,658.68
Rahul Bhardwaj Loma Linda, CA Clinical Cardiac Electrophysiology $1,625.25
Anil Purohit Indianapolis, IN Clinical Cardiac Electrophysiology $1,600.00

Prescribed Edora 8 Dr-T?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.